Abstract
Leprosy is a chronic mycobacterial disease caused by Mycobacterium leprae. Worldwide, there are about 10 million to 15 million people suffering from this disease. It is not only the number of patients but also the disabilities inflicted on them that have made leprosy among the priority diseases to be controlled and eventually eradicated. Man is the only known natural host of M. leprae, and it is from man to man that the disease seems to be carried. For the successful control of leprosy, two approaches have been advocated.
This is a preview of subscription content, log in via an institution.
Buying options
Tax calculation will be finalised at checkout
Purchases are for personal use only
Learn about institutional subscriptionsPreview
Unable to display preview. Download preview PDF.
References
Convit J, Aranazu N, Ulrich M, et al: Investigations related to the development of a leprosy vaccine. Int J Lepr 1983; 51: 531–539.
Deo MG, Bapat CV, Bhalerao V, et al: Antileprosy potentials of ICRC vaccine: a study in patients and healthy volunteers. Int J Lepr 1983; 51: 540–549.
Dharmendra, Chatteijee KR: Prognostic value of the lepromin test in contacts of leprosy cases. Lepr India 1955; 27: 149–152.
Engers HD, Bloom BR, Godal T: Monoclonal antibodies against mycobacterial antigens. Immunol Today 1985; 6: 345–348.
Gill HK, Mustafa AS, Godal T: Induction of delayed-type hypersensitivity in human volunteers immunized with a candidate leprosy vaccine consisting of killed Mycobacterium leprae. Bull WHO 1986; 64: 121–126.
Gill HK, Mustafa AS, Ivanyi J, et al: Humoral immune responses to M. leprae in human volunteers vaccinated with killed, armadillo derived M. leprae. Lepr Rev 1986; 57 (suppl 2): 293–300.
Gill HK, Mustafa AS, Godal T: In vitro proliferation of lymphocytes from human volunteers vaccinated with armadillo-derived, killed M. leprae. Int J Lepr 1987; 55: 30–35.
Godal T: Immunological aspects of leprosy—present status. Prog Allergy 1978; 25: 211–242.
Graham L Jr, Navalkar RG: Evaluation of Mycobacterium leprae immuno-genicity via adoptive transfer studies. Infect Immun 1984; 43: 79–83.
Kaufmann SHE, Chiplunkar S, Flesch I, de Libero G: Possible role of helper and cytolytic T cells in mycobacterial infections. Lepr Rev 1986; 57 (suppl 2): 101–111.
Kirchheimer WF, Storrs EE: Attempts to establish the armadillo (Dasypus novemcinctus Linn.) as a model for the study of leprosy. I. Report of lepro- matoid leprosy in an experimentally infected armadillo. Int J Lepr 1971, 39: 693–702.
Kirchheimer WF, Storrs EE, Binford CH: Attempts to establish the armadillo (Dasypus novemcinctus Lynn.) as a model for the study of leprosy. II. Histologic and bacteriologic post-mortem findings in lepromatoid leprosy in the armadillo. Int J Lepr 1972; 40: 229–242.
Mehra V, Bloom BR: Induction of cell mediated immunity to Mycobacterium leprae in mice. Infect Immun 1979; 23: 787–994.
Mehra V, Brennan PJ, Rada E, et al: Lymphocyte suppression in leprosy induced by unique M. leprae glycolipid. Nature 1984; 308: 194–196.
Mehra V, Sweester D, Young RA: Efficient mapping of protein antigenic determinants. Proc Natl Acad Sei USA 1986; 83: 7013–7017.
Mustafa AS, Gill HK, Nerland A, et al: Human T-cell clones recognize a major M. leprae protein antigen expressed in E. coli. Nature 1986; 319: 63 - 66.
Mustafa AS, Oftung F, Gill HK, Natvig I: Characteristics of human T cell clones from BCG and killed M. leprae vaccinated subjects and tuberculosis patients: recognition of recombinant mycobacterial antigens. Lepr Rev 1986; 57 (supply 2): 123 - 130.
Mustafa AS, Kvalheim G, Degre M, Godal T: Mycobacterium bovis BCG induced human T cell clones from BCG vaccinated healthy subjects: antigen specificity and lymphokine production. Infect Immun 1986; 53: 491–497.
Mustafa AS, Godal T: BCG induced CD4+ cytotoxic T cells from BCG vaccinated healthy subjects: relation between cytotoxicity and suppression in vitro. Clin Exp Immunol 1987; 69: 255–262.
Oftung F, Mustafa AS, Husson R, et al: Human T cell clones recognize two abundant Mycobacterium tuberculosis protein antigens expressed in Escherichia coli. J Immunol 1987; 138: 927–931.
Patel PJ, Lefford MJ: Induction of cell-mediated immunity to Mycobacterium leprae in mice. Infect Immun 1979; 19: 87–93.
Pönnighaus JM, Fine PEM: The Karonga prevention trial—which BCG? Lepr Rev 1986; 57 (suppl 2): 285–292.
Shepard CC: The experimental disease that follows the injection of human leprosy bacilli into foot-pads of mice. J Exp Med 1960; 112: 445–454.
Shepard CC: Animal vaccination studies with Mycobacterium leprae. Int J Lepr 1984; 51: 519–523.
Shepard CC, Walker LL, van Landingham R: Heat stability of Mycobacterium leprae immunogenicity. Infect Immun 1978; 22: 87–93.
Shepard Draper P, Rees RJW, Lowe C: Effect of purification steps on the immunogenicity of Mycobacterium leprae. Br J Exp Pathol 1980; 61: 375–379.
Shepard CC, Minagawa F, van Landingham R, Walker LL: Foot pad enlargement as a measure of induced immunity to Mycobacterium leprae. Int J Lepr 1980; 48: 371–381.
Smelt AHM, Rees RJW, Liew FY: Induction of delayed-type hypersensitivity to Mycobacterium leprae in healthy individuals. Clin Exp Immunol 1981; 44: 501–506.
Talwar GP, Fotedar A: Two candidate anti-leprosy vaccines—current status of their development. Int J Lepr 1983; 51: 550–552.
World Health Organization: Report of the Fifth Meeting of the Scientific Working Group on the Immunology of Leprosy. Protocol 1/79. TDR/SWG/ IMMLEP (5) 80. 3, 1980.
Young RA, Mehra V, Sweester D, et al: Genes for the major protein antigens of the leprosy parasite Mycobacterium leprae. Nature 1985; 316: 450–452.
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 1989 Springer-Verlag New York Inc.
About this paper
Cite this paper
Mustafa, A.S. (1989). Armadillo-Derived Killed M. leprae: Candidate Vaccine Against Leprosy. In: Talwar, G.P. (eds) Progress in Vaccinology. Progress in Vaccinology, vol 2. Springer, New York, NY. https://doi.org/10.1007/978-1-4612-3508-8_29
Download citation
DOI: https://doi.org/10.1007/978-1-4612-3508-8_29
Publisher Name: Springer, New York, NY
Print ISBN: 978-0-387-96734-9
Online ISBN: 978-1-4612-3508-8
eBook Packages: Springer Book Archive